BEST Profitable Penny Stock With Insider Buying

Here’s Why CHUC Insiders May Be Buying Shares In Open Market

When company insiders purchase shares with their own money, it often signals that they believe the market’s assessment of their company’s future prospects is misunderstood or underappreciated.

That appears to be the case with Charlie’s Holdings OTCQB:CHUC 

On December 17, CHUC President Henry Sicignano purchased 100,000 shares in the open market.

This followed another insider buy that now looks far more strategic than it first appeared.

On September 9, Dr. Edward Carmines bought CHUC shares in the open market. Dr. Carmines is not just a director at Charlie’s. He is also the Chief Scientific Officer at Chemular, a company deeply involved in the technology Charlie’s is developing for the future of nicotine products.

Earlier this year, Charlie’s issued a secured promissory note to Chemular to resolve outstanding payables (before the Company realized a $7.5MM gain on a strategic transaction with one of the world’s largest tobacco companies).

Along with Chemular’s promissory note came 3.7 million warrants, which were fully exercised on September 24.

What matters here is timing. Dr. Carmines bought CHUC shares before those warrants were exercised, not after.

Chemular is also a partner in IKE Tech, a joint venture focused on secure age verification and biometric authentication.

That technology sits at the center of Charlie’s long term strategy.

This Penny Stock Could Disrupt A Massive Industry

Charlie’s has publicly stated it is developing age gating technology that will allow its vapor products to function only after verifying the user is an adult consumer.

This is not a “pie in the sky” endeavor. In a recent CEO interview, Henry explained that the project is being led by Dr. Edward Carmines himself.

Dr. Carmines is widely regarded as one of the most experienced scientists in the nicotine and vapor industry. He has successfully guided hundreds of products through FDA pathways, including Premarkt Tobacco Applications (PMTAs) and Modified Risk Tobacco Product applications.

In addition to serving on the Company’s Board of Directors, his work with Charlie’s is aimed at creating an age-gated FLAVORED e-cigarette that will be legal in the highly lucrative U.S. market.

If the FDA recognizes these age-gated products as “products of merit,” Charlie’s could become the first  ̶  and ultimately one of the very few companies  ̶  allowed to legally sell flavored e-cigarettes (preferred by 85% of adult consumers).

That is an $8 BILLION market… that could actually grow, very substantially, with the advent of legal, flavored products.

See Why CHUC Insiders Might Be Buying?

Now zoom out to the global picture.

On December 5, Chinese Premier Li Qiang chaired a State Council executive meeting and explicitly called for a full chain crackdown on illicit tobacco and vaping-related activities.

This message was later broadcast on Xinwen Lianbo, China’s most authoritative national news program.

In China’s system, this matters. When enforcement messages come from the very top of the central government and are publicly amplified, it signals coordinated nationwide action.

This was not a routine departmental announcement. It was a clear and rare statement that illicit tobacco and novel vaping products are now a priority enforcement target.

The takeaway is simple: China appears to be entering a phase of intensified regulation and concentrated enforcement against illegal and non-compliant tobacco and vaping products.

This overseas pressure mirrors what is already happening in the United States.

Back at home, a Goldman Sachs analyst recently told clients to “Buy Nicotine.”

Goldman cannot highlight penny stocks and did not mention CHUC.

But those familiar with Henry’s past leadership at XXII know that this same analyst previously featured his company on a listening tour with select institutional clients.

Keep in mind, Charlie’s has publicly stated that an uplist from the OTCQB to a national securities exchange is a 2026 corporate priority.

Then came another regulatory domino.

The day after Henry bought shares, Pennsylvania’s PMTA registry bill landed on the governor’s desk.

If signed, it will restrict access to many vaping products in the state.

Pennsylvania becomes the fourth state this year to pass such a law. Fourteen states now have PMTA registry laws in place, with more considering them.

Each new registry law removes non-compliant products from the market. At the same time, it increases the value of companies that already hold PMTA approvals or are developing compliant, age-verified technology.

That is where CHUC’s SBX product line and PMTA strategy come into focus.

Seen together, insider buying, tightening U.S. regulations, China’s top-down enforcement signal, and Charlie’s weighty investments in age-gating technology all point in the same direction.

The nicotine market is not disappearing.

It is trending toward compliance, youth access prevention, and domestic manufacturing… all three areas in which Charlie’s excels.

The people closest to Charlie’s appear to believe the company is (very) well-positioned to thrive in the new vapor products marketplace. 

We tend to agree!

Other Articles About Charlie’s Holdings OTCQB:CHUC

• OTCQB:CHUC Best Nicotine Vape Stock
• Big Tobacco Quietly Acquires CHUC PMTAs
• OTCQB:CHUC Investor Deck
• CHUC’s Latest Shareholder Letter
• Charlie’s Holdings OTCQB: CHUC Oct 2025 Interview

Charlie’s Holdings OTCQB:CHUC

Charlie’s Holdings, Inc. (OTCQB: CHUC) is an industry leader in the premium vapor products space.

To provide adult smokers with better alternatives to combustible cigarettes, Charlie’s has developed a family of award-winning e-liquids as well as an array of compact, easy-to-use disposable vaping devices.

The Company’s products are sold around the world to select distributors, specialty retailers, and third-party online resellers.

Many store owners report that Charlie’s vapor products are among their fastest growing offerings. 

Safe Harbor Statement: This interview contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company’s overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company’s ability to successfully increase sales and enter new markets; whether the Company’s PMTA’s for its nicotine-containing products will be authorized by the FDA, and the FDA’s decisions with respect to the Company’s future PMTA’s for nicotine products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, and products containing nicotine substitutes; litigation risks from the use of the Company’s products; risks of government regulations; the impact of competitive products; and the Company’s ability to maintain and enhance its brands, as well as other risk factors included in the Company’s most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this interview and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this interview as a result of new information, future events or changes in its expectations.

Artificial Intelligence Stock Reading

• The Best Artificial Intelligence Penny Stock VERSES AI
• Artificial Intelligence Stock with BIGGEST Potential
• What is BETTER than ChatGPT Generative Artificial Intelligence
• Generative Artificial Intelligence Regulation Solution
• How To Govern and Regulate Artificial Intelligence
• The BEST C3 AI Stock Alternative
• Next Generation Intelligence Patent Application
• The ONLY Adaptive Artificial Intelligence Stock
• Artificial Intelligence Stocks
• VERSES VRSSF 2023 Year End Summary
• The Story of VERSES AI VRSSF
• How VERSES AI Solves the Generative AI Problem